| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |